Stopped
CAR-T,MTD · CD30 CAR-T · CD30 Positive Lymphoma
Recruitment suspended
And 2 more changes in the last 30 days
Shandong Qilu Cell Therapy Engineering Technology Co., LtdEarly Phase 1 NCT07048353 Registry history of NCT07048353 on ClinicalTrials.gov (opens the registry)